BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 7361006)

  • 1. Contribution of gut contents, intestinal wall and liver to the first-pass metabolism of clonazepam in the rat.
    Colburn WA; Bekersky I; Min BH; Hodshon BJ; Garland WA
    Res Commun Chem Pathol Pharmacol; 1980 Jan; 27(1):73-90. PubMed ID: 7361006
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of the intestinal microflora in clonazepam metabolism in the rat.
    Elmer GW; Remmel RP
    Xenobiotica; 1984 Nov; 14(11):829-40. PubMed ID: 6506755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proceedings: Blood level, excretion, distribution and metabolism of 14C-triflubazam, a new 1,5-benzodiazepine, in mice and dogs.
    Bechtel WD
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(Suppl):suppl 282:R6. PubMed ID: 4276517
    [No Abstract]   [Full Text] [Related]  

  • 4. Role of gut contents, intestinal wall, and liver on the first pass metabolism and absolute bioavailability of isotretinoin in the dog.
    Cotler S; Buggé CJ; Colburn WA
    Drug Metab Dispos; 1983; 11(5):458-62. PubMed ID: 6138231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo O-de-ethylation of phenacetin in 3-methylcholanthrene-pretreated rats: gut wall and liver first-pass metabolism.
    Klippert PJ; Littel RJ; Noordhoek J
    J Pharmacol Exp Ther; 1983 Apr; 225(1):153-7. PubMed ID: 6834267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of clonazepam in the dog.
    Al-Tahan F; Löscher W; Frey HH
    Arch Int Pharmacodyn Ther; 1984 Apr; 268(2):180-93. PubMed ID: 6732363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic profile of clonazepam in rhesus monkeys.
    Lai AA; Levy RH
    J Pharm Sci; 1978 Mar; 67(3):295-9. PubMed ID: 417166
    [No Abstract]   [Full Text] [Related]  

  • 8. Hepatic and intestinal first-pass effects of oltipraz in rats.
    Bae SK; Kim JW; Kim YH; Kim YG; Kim SG; Lee MG
    Biopharm Drug Dispos; 2005 May; 26(4):129-34. PubMed ID: 15744718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose-independent pharmacokinetics of ondansetron in rats: contribution of hepatic and intestinal first-pass effects to low bioavailability.
    Yang SH; Lee MG
    Biopharm Drug Dispos; 2008 Oct; 29(7):414-26. PubMed ID: 18697186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of sildenafil after intravenous and oral administration in rats: hepatic and intestinal first-pass effects.
    Shin HS; Bae SK; Lee MG
    Int J Pharm; 2006 Aug; 320(1-2):64-70. PubMed ID: 16730145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Metabolic drug interactions of carbamazepine and clonazepam].
    Borchert HH; Szołomicka-Orfinger I; Pfeifer S
    Pharmazie; 1978 Dec; 33(12):816-20. PubMed ID: 746068
    [No Abstract]   [Full Text] [Related]  

  • 12. Determination of the enzyme(s) involved in the metabolism of amiodarone in liver and intestine of rat: the contribution of cytochrome P450 3A isoforms.
    Shayeganpour A; El-Kadi AO; Brocks DR
    Drug Metab Dispos; 2006 Jan; 34(1):43-50. PubMed ID: 16204463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of atorvastatin and its hydroxy metabolites in rats and the effects of concomitant rifampicin single doses: relevance of first-pass effect from hepatic uptake transporters, and intestinal and hepatic metabolism.
    Lau YY; Okochi H; Huang Y; Benet LZ
    Drug Metab Dispos; 2006 Jul; 34(7):1175-81. PubMed ID: 16624870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolism of 14C-5HT in experimental liver cirrhosis in the rat.
    Pentikäinen P; Kekki M; Mustala O
    Scand J Gastroenterol Suppl; 1969; 4():1-33. PubMed ID: 5270654
    [No Abstract]   [Full Text] [Related]  

  • 15. Polymorphic acetylation of 7-amino-clonazepam in human liver cytosol.
    Peng DR; Birgersson C; von Bahr C; Rane A
    Pediatr Pharmacol (New York); 1984; 4(3):155-9. PubMed ID: 6493838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentiation of absorption and first-pass gut and hepatic metabolism in humans: studies with cyclosporine.
    Wu CY; Benet LZ; Hebert MF; Gupta SK; Rowland M; Gomez DY; Wacher VJ
    Clin Pharmacol Ther; 1995 Nov; 58(5):492-7. PubMed ID: 7586942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of pharmacokinetics, brain levels and protein binding of centpropazine in rats.
    Bhattaram VA; Paliwal JK; Gupta RC
    Biopharm Drug Dispos; 2004 Mar; 25(2):69-75. PubMed ID: 14872554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of dexamethasone on the intestinal first-pass metabolism of indinavir in rats: evidence of cytochrome P-450 3A [correction of P-450 A] and p-glycoprotein induction .
    Lin JH; Chiba M; Chen IW; Nishime JA; deLuna FA; Yamazaki M; Lin YJ
    Drug Metab Dispos; 1999 Oct; 27(10):1187-93. PubMed ID: 10497146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic and intestinal first-pass effects of a new hepatoprotective agent, YH439, in rats.
    Kim J; Han KS; Lee JW; Lee MG
    Res Commun Mol Pathol Pharmacol; 1998 Nov; 102(2):125-36. PubMed ID: 10100504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nitroreduction of clonazepam in human foetal liver microsomes and hepatocyte cultures.
    Peng DR; Petters I; Rane A
    Biochem Soc Trans; 1984 Feb; 12(1):39-42. PubMed ID: 6546727
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.